Back to search

Article

Repurposing celecoxib for ovarian cancer treatment by targeting survivin signaling

2023-01-06

Abstract excerpt

<title>Abstract</title> <p>Background Ovarian cancer is the leading cause of deaths among gynecologic cancers. With a five-year survival rate just slightly above 45% and high rates of chemo-toxicity and chemo-resistance, the search for novel, more effective, and less toxic therapeutic approaches is thus imperative. In the current study, we aimed to explore the potential antitumor effect of a COX-2 inhibitor, cel...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eacebb04-652d-554b-892f-169d35c6391f
DOI
10.21203/rs.3.rs-2429733/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Repurposing celecoxib for ovarian cancer treatment by targeting survivin signalingDOI 10.21203/rs.3.rs-2429733/v1
Select a neighboring publication to make it the new centre.